Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04227522
Title Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients (MAMOC)
Acronym MAMOC
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.